Effects of therapeutic hypercapnia on inflammation and apoptosis after hepatic ischemia-reperfusion injury in rats

Chinese Medical Journal

Volumn 123, Issue 16, 2010, Pages 2254-2258

  Li, Ai Min ^a   Quan, Yan ^a   Guo, Yue Ping ^a   Li, Wen Zhi ^a   Cui, Xiao Guang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CO2 preconditioning; Hypercapnia; Ischemia reperfusion injury; Liver

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; BLOOD PH; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOHISTOCHEMISTRY; INDUCED HYPERCAPNIA; INFLAMMATION; ISCHEMIC PRECONDITIONING; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER NECROSIS; MAINTENANCE OF RESPIRATION AND CIRCULATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CARBON DIOXIDE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLAMMATION; INTERLEUKIN-10; LIVER; MALE; NF-KAPPA B; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956099527     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936
2. Luedde T, Liedtke C, Manns MP, Trautwein C. Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure. Eur Cytokine Netw 2002; 13: 377-383.
3. Knolle PA. Involvement of the liver in the induction of CD8 T cell tolerance towards oral antigen. Z Gastroenterol 2006; 44: 51-56.
4. Goto M, Takei Y, Kawano S, Tsuji S, Fukui H, Fushimi H, et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology 1992; 16: 487-493.
5. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 1995; 27: 537-541.
6. Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, et al. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology 2003; 38: 335-344.
7. Luckey SW, Taylor M, Sampey BP, Scheinman RI, Petersen DR. 4-hydroxynonenal decreases interleukin-6 expression and protein production in primary rat Kupffer cells by inhibiting nuclear factor-kappaB activation. J Pharmacol Exp Ther 2002; 302: 296-303.
8. Essani NA, McGuire GM, Manning AM, Jaeschke H. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 1996; 156: 2956-2963.
9. Ni Chonghaile M, Higgins B, Laffey JG. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care 2005; 11: 56-62.
10. Morisaki H, Yajima S, Watanabe Y, Suzuki T, Yamamoto M, Katori N, et al. Hypercapnic acidosis minimizes endotoxin-induced gut mucosal injury in rabbits. Intensive Care Med 2009; 35: 129-135.
11. Laffey JG, Jankov RP, Engelberts D, Tanswell AK, Post M, Lindsay T, et al. Effects of therapeutic hypercapnia on mesenteric ischemia-reperfusion injury. Am J Respir Crit Care Med 2003; 168: 1383-1390.
12. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ. Role of neutrophils during the first 24 hours after liver ischemia and reperfusion injury. Transplant Proc 1994; 26: 3695-3700.
13. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89: 2637-2645.
14. Nauta RJ, Tsimoyiannis E, Uribe M, Walsh DB, Miller D, Butterfield A. Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet 1990; 171: 120-125.
15. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA, Jr. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-1943.
16. Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009; 36: 4-12.
17. Alessenko AV, Galperin EI, Dudnik LB, Korobko VG, Mochalova ES, Platonova LV, et al. Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apoptosis by ischemia/reperfusion of the liver. Biochemistry (Mosc) 2002; 67: 1347-1355.
18. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 1999; 30: 203-208.
19. Hamada T, Tsuchihashi S, Avanesyan A, Duarte S, Moore C, Busuttil RW, et al. Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury. J Immunol 2008; 180: 1843-1853.
20. Suetsugu H, Iimuro Y, Uehara T, Nishio T, Harada N, Yoshida M, et al. Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 2005; 54: 835-842.
21. Xu J, Yang Z, Zeng J. Role of NF-kappa B in liver ischemia reperfusion injury of rats. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 158-160.
22. Takeshita K, Suzuki Y, Nishio K, Takeuchi O, Toda K, Kudo H, et al. Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-[kappa]B activation. Am J Respir Cell Mol Biol 2003; 29: 124-132.